Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes
Completed
- Conditions
- Foot UlcerDiabetic FootDiabetic NeuropathiesDiabetes Mellitus
- Interventions
- Other: Becaplermin nonusers
A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes Mellitus
Phase 2
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2010-10-29
- Last Posted Date
- 2013-12-11
- Target Recruit Count
- 89
- Registration Number
- NCT01230749
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
- Conditions
- Prostate NeoplasmsGenital Neoplasms, MaleUrogenital NeoplasmsGenital Diseases, Male
An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain
Phase 3
Completed
- Conditions
- Pain
- Interventions
- First Posted Date
- 2010-09-20
- Last Posted Date
- 2014-02-03
- Target Recruit Count
- 260
- Registration Number
- NCT01205126
A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male Volunteers
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2014-05-16
- Target Recruit Count
- 10
- Registration Number
- NCT01202734
A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Canagliflozin/Warfarin
- First Posted Date
- 2010-09-06
- Last Posted Date
- 2014-05-08
- Target Recruit Count
- 14
- Registration Number
- NCT01195324
A Relative Bioavailability Study of Rabeprazole Sodium Administered With Different Dosing Vehicles in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2010-08-23
- Last Posted Date
- 2013-01-23
- Target Recruit Count
- 35
- Registration Number
- NCT01186497
A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function
- First Posted Date
- 2010-08-23
- Last Posted Date
- 2013-05-29
- Target Recruit Count
- 24
- Registration Number
- NCT01186588
A First-in-Human Study of JNJ-28431754 in Healthy Male Volunteers
- First Posted Date
- 2010-08-06
- Last Posted Date
- 2010-08-11
- Target Recruit Count
- 71
- Registration Number
- NCT01177150
A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: PlaceboDrug: JNJ 28431754 100 mg/placeboDrug: JNJ 28431754 300 mg/placebo
- First Posted Date
- 2010-08-06
- Last Posted Date
- 2013-05-29
- Target Recruit Count
- 29
- Registration Number
- NCT01177163
© Copyright 2025. All Rights Reserved by MedPath